Anti-TCEA1 antibody
Specifications
| Product Cat#: | AB-06-4916 |
| Product type: | Primary antibody |
| Antigen: | TCEA1 |
| Immunogen: | Synthetic peptide within human TCEA1 aa 201-250/301. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400-1:2000); Immunohistochemistry-Paraffin (1:200-1:400) |
| Reactivity: | Human, Rat, Mouse |
| Clonality (clone number): | Monoclonal, JE64-90 |
| Form: | Liquid |
| Buffer: | 1*TBS buffer (pH7.4), 0.05% BSA, 40% Glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified. |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Conjugate: | Unconjugated |
| Alternative names: | GTF2S antibody |
| SII antibody | |
| TCEA antibody | |
| Tcea1 antibody | |
| TCEA1_HUMAN antibody | |
| TF2S antibody | |
| TFIIS antibody | |
| Transcription elongation factor A (SII) 1 antibody | |
| Transcription elongation factor A protein 1 antibody | |
| Transcription elongation factor A, 1 antibody | |
| Transcription elongation factor S-II protein 1 antibody | |
| Transcription elongation factor TFIIS.o antibody |
Show More
Target information
TCEA1 (Transcription Elongation Factor A1) is a Protein Coding gene. Diseases associated with TCEA1 include Cockayne Syndrome and Transverse Colon Cancer. Among its related pathways are HIV Life Cycle and Tat-mediated elongation of the HIV-1 transcript. Gene Ontology (GO) annotations related to this gene include nucleic acid binding and translation elongation factor activity. An important paralog of this gene is TCEA2.
Provider
Erpantech Laboratory
